Bianca Miller
Biochemistry and Molecular Biology | Biotechnology
Research Topic: Targeting the PI3K Pathway using Multi-Target Tyrosine Kinase Inhibitors in a Discoideum Model of Metastasis
Research Poster Located in the Neighborhood Engagement Centers
Research Summary:
Bianca's research aimed to determine the safety and efficacy of anlotinib to treat metastatic cancers using Dictyostelium disocideum as a model for the PI3K pathway. This research concluded that anlotinib is working correctly if apoptosis is induced or if the formation of streams, mounds, and fruiting bodies in D. discoideums are negatively affected.
